NeuroBell secures €2.1m to launch device that detects seizures in babies

UCC spin-out currently seeking FDA approval for its pocked-sized device with an intention to launch the solution commercially in 2025 at the latest

NeuroBell founders: Dr Mark O’Sullivan, Colm Murphy and Dr Alison O’Shea

NeuroBell, a University Cork College spin-out, has raised €2.1 million from investors as it looks to go to market with a medical device to accurately detect seizures in newborn babies.

Founded by Dr Mark O’Sullivan, Dr Alison O’Shea and Colm Murphy, NeuroBell is aiming to address a gap in the availability and accuracy of technologies used to detect seizures in newborns admitted to neonatal intensive care units.

Early detection of seizures is crucial for enabling ...